Sofetabart mipitecan is an antibody-drug conjugate consisting of an Fc-silent, folate receptor alpha specific monoclonal antibody attached to an exatecan payload.
Valneva withdrew its chikungunya vaccine applications following a license suspension and data suggesting a probable link to serious adverse outcomes.
No main effect of treatment seen on reduction of total number of cannabis use sessions per week, but significant treatment-by-sex interaction reported.
HealthDay News — A powdered super greens supplement sold across the US has been recalled after federal health officials linked it to a Salmonella outbreak that has sickened people in at least 21 ...
Bradycardia on initial ED vital signs associated with higher likelihood of xylazine detection in patients with opioid overdose ...
HealthDay News — Patients with chronic illnesses face a significantly higher risk for complications from cosmetic botulinum toxin (BoNT) injections, according to a study recently published in the ...
Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.
However, relief does not translate into measurable improvements in visual task performance or tear film metrics ...
Strategy is feasible for advanced cancers; 157 regimens were administered to 210 patients, including 103 personalized combos ...
Prevalence, treatment utilization described for hypertension, diabetes mellitus, obesity, LDL-C, and cigarette smoking.
Higher rates of glaucoma therapy seen at increasing IOP levels, with cutoff of 22 mm Hg influencing clinician decision-making ...
FDA grants Breakthrough Therapy designation to ianalumab for Sjögren disease after the monoclonal antibody showed significant disease improvement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results